Atlas Trials

A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy

Clinical trial NCT01681121 · COMPLETED

Trial details

NCT number
NCT01681121
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Narcolepsy
Start date
2012-09-01
Primary completion
2013-08-01
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.